C20ORF72 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.443800E-01
Normal-vs-Stage2
5.616200E-01
Normal-vs-Stage3
2.182400E-01
Normal-vs-Stage4
2.953800E-01
Stage1-vs-Stage2
7.393200E-01
Stage1-vs-Stage3
3.140200E-01
Stage1-vs-Stage4
5.746800E-01
Stage2-vs-Stage3
1.367590E-01
Stage2-vs-Stage4
3.566200E-01
Stage3-vs-Stage4
6.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.459800E-01
Normal-vs-AfricanAmerican
4.621800E-01
Normal-vs-Asian
4.703000E-01
Caucasian-vs-AfricanAmerican
5.658000E-01
Caucasian-vs-Asian
4.869600E-01
AfricanAmerican-vs-Asian
9.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.066000E-01
Normal-vs-Female
2.293600E-01
Male-vs-Female
2.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.504600E-01
Normal-vs-Age(41-60Yrs)
6.110000E-01
Normal-vs-Age(61-80Yrs)
5.015600E-01
Normal-vs-Age(81-100Yrs)
6.013800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.291640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.160400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.225500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.133180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.318200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.221800E-01
Normal-vs-Daily Drinker
4.694800E-01
Normal-vs-Weekly Drinker
5.217000E-01
Normal-vs-Occasional Drinker
5.903200E-01
Normal-vs-Social Drinker
5.701200E-01
Non Drinker-vs-Daily Drinker
5.737800E-01
Non Drinker-vs-Weekly Drinker
7.505000E-01
Non Drinker-vs-Occasional Drinker
5.607400E-01
Non Drinker-vs-Social Drinker
6.977400E-01
Daily Drinker-vs-Weekly Drinker
5.572200E-01
Daily Drinker-vs-Occasional Drinker
2.460000E-01
Daily Drinker-vs-Social Drinker
3.420400E-01
Weekly Drinker-vs-Occasional Drinker
9.918000E-01
Weekly Drinker-vs-Social Drinker
9.206400E-01
Occasional Drinker-vs-Social Drinker
8.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.703600E-01
Normal-vs-Grade 2
7.202000E-01
Normal-vs-Grade 3
7.625000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.522200E-02
Grade 1-vs-Grade 3
1.475870E-03
Grade 1-vs-Grade 4
6.703600E-01
Grade 2-vs-Grade 3
4.228200E-02
Grade 2-vs-Grade 4
7.202000E-01
Grade 3-vs-Grade 4
7.625000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.615600E-01
Normal-vs-NonDiabetic
5.370800E-01
Diabetic-vs-NonDiabetic
2.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.280600E-01
Normal-vs-NoPancreatitis
5.245200E-01
Pancreatitis-vs-NoPancreatitis
3.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.273400E-01
Normal-vs-N1
5.578600E-01
N0-vs-N1
6.408400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.637000E-01
Normal-vs-TP53-NonMutant
6.056800E-01
TP53-Mutant-vs-TP53-NonMutant
6.161700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
